The Philadelphia Phillies’ divisional rivals faced a significant setback when they placed their ace on the injured list due to a season-ending injury. The Phillies themselves have had a mixed start to the season, currently holding a.500 record as of Saturday. Despite strong pitching performances from their starters, the offense has struggled, hindering their progress.
However, there is a silver lining as the Phillies’ starting rotation continues to showcase itself as one of the top units in the league. Meanwhile, their hitters are working through their challenges. In a notable development for the divisional race, the Atlanta Braves made a major move by officially placing Spencer Strider on the injured list. Strider underwent season-ending surgery to repair a damaged UCL in his throwing elbow, reshaping the competitive landscape within the division.
According to Mark Polishuk of MLB Trade Rumors, Spencer Strider opted for an internal brace surgery instead of the more traditional Tommy John procedure to address his torn UCL. This decision is noteworthy, especially considering Strider’s previous Tommy John surgery in 2019 during his time at Clemson University. Despite his strong debut season in 2021 and consistent appearances in over 30 games each subsequent season, Strider’s injury has sidelined him for the remainder of the year.
While internal brace surgeries are still relatively new, they are perceived as less invasive compared to Tommy John surgery. Nonetheless, Strider’s absence poses a significant setback for the Braves and their rotation.
In 2023, Strider led the MLB in wins with 20 and strikeouts with 28, earning him fourth place in NL Cy Young voting. Although the Braves possess considerable depth, this injury undoubtedly impacts their competitiveness and bolsters the Phillies’ chances of clinching the NL East title for the first time since 2011.